2016 updated EULAR evidence-based recommendations for the management of gout
Background New drugs and new evidence concerning the use of established treatments
have become available since the publication of the first European League Against …
have become available since the publication of the first European League Against …
[HTML][HTML] Gout: An old disease in new perspective–A review
G Ragab, M Elshahaly, T Bardin - Journal of advanced research, 2017 - Elsevier
Gout is a picturesque presentation of uric acid disturbance. It is the most well understood
and described type of arthritis. Its epidemiology is studied. New insights into the …
and described type of arthritis. Its epidemiology is studied. New insights into the …
[HTML][HTML] The British Society for Rheumatology guideline for the management of gout
M Hui, A Carr, S Cameron, G Davenport… - …, 2017 - academic.oup.com
Gout is the most common cause of inflammatory arthritis worldwide. In UK general practice,
the overall prevalence has increased from 1.4% in 1999 to 2.49% in 2012 [1], despite the …
the overall prevalence has increased from 1.4% in 1999 to 2.49% in 2012 [1], despite the …
[HTML][HTML] Physiology of hyperuricemia and urate-lowering treatments
CL Benn, P Dua, R Gurrell, P Loudon, A Pike… - Frontiers in …, 2018 - frontiersin.org
Gout is the most common form of inflammatory arthritis and is a multifactorial disease
typically characterized by hyperuricemia and monosodium urate crystal deposition …
typically characterized by hyperuricemia and monosodium urate crystal deposition …
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to …
D Khanna, JD Fitzgerald, PP Khanna… - Arthritis care & …, 2012 - Wiley Online Library
Gout is a disorder that manifests as a spectrum of clinical and pathologic features built on a
foundation of an excess body burden of uric acid, manifested in part by hyperuricemia …
foundation of an excess body burden of uric acid, manifested in part by hyperuricemia …
Safety and tolerability of available urate-lowering drugs: a critical review
Introduction: Urate-lowering therapy (ULT) is the cornerstone of gout management, which is
a widespread chronic illness characterized by hyperuricemia, arthropathy, tophus …
a widespread chronic illness characterized by hyperuricemia, arthropathy, tophus …
Hyperuricemia and cardiovascular disease
S Zhang, Y Wang, J Cheng, N Huangfu… - Current …, 2019 - ingentaconnect.com
Purine metabolism in the circulatory system yields uric acid as its final oxidation product,
which is believed to be linked to the development of gout and kidney stones. Hyperuricemia …
which is believed to be linked to the development of gout and kidney stones. Hyperuricemia …
Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad …
F Sivera, M Andrés, L Carmona, ASR Kydd… - Annals of the …, 2014 - ard.bmj.com
We aimed to develop evidence-based multinational recommendations for the diagnosis and
management of gout. Using a formal voting process, a panel of 78 international …
management of gout. Using a formal voting process, a panel of 78 international …
Pathogenesis of acute stroke and the role of inflammasomes
Inflammation is an innate immune response to infection or tissue damage that is designed to
limit harm to the host, but contributes significantly to ischemic brain injury following stroke …
limit harm to the host, but contributes significantly to ischemic brain injury following stroke …
Pyroptotic neuronal cell death mediated by the AIM2 inflammasome
SE Adamczak, JP de Rivero Vaccari… - Journal of Cerebral …, 2014 - journals.sagepub.com
The central nervous system (CNS) is an active participant in the innate immune response to
infection and injury. In these studies, we show embryonic cortical neurons express a …
infection and injury. In these studies, we show embryonic cortical neurons express a …